Gynaecological cancers
157 results
1 - 100
Centralisation of services for gynaecological cancer- Management of drainage for malignant ascites in gynaecological cancer
- Robotic assisted surgery for gynaecological cancer
- Perioperative enhanced recovery programmes for women with gynaecological cancers
- Patient‐reported outcome measures for follow‐up after gynaecological cancer treatment
- Interventions to improve psychosexual function in women treated for gynaecological cancers
- Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer
- Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer
- Exenterative surgery for recurrent gynaecological malignancies
- Interventions for psychosexual dysfunction in women treated for gynaecological malignancy
- Robot‐assisted surgery in gynaecology
- Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies
- Laparoscopy versus laparotomy for FIGO stage I ovarian cancer
- Hysterectomy with opportunistic salpingectomy versus hysterectomy alone
- Follow‐up protocols for women with cervical cancer after primary treatment
- Interval debulking surgery for advanced epithelial ovarian cancer
- Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses
- Pre‐treatment surgical para‐aortic lymph node assessment in locally advanced cervical cancer
- Surgical treatment of stage IA2 cervical cancer
- Perioperative nutrition interventions for women with ovarian cancer
- Lymphadenectomy or sentinel node biopsy for the management of endometrial cancer
- Total versus subtotal hysterectomy for benign gynaecological conditions
- Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer
- Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women
- Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer
- Chemotherapy for metastatic and recurrent cervical cancer
- Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancer
- Chemoradiation for advanced primary vulval cancer
- Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations
- Dietary interventions for adult cancer survivors
- Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer
- Epidermal growth factor receptor blockers for the treatment of ovarian cancer
- Green tea (Camellia sinensis) for the prevention of cancer
- Tamoxifen for relapse of ovarian cancer
- Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma
- Intra‐peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction after non‐gynaecological abdominal surgery
- Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma: Cochrane systematic review
- Optimal primary surgical treatment for advanced epithelial ovarian cancer
- Topotecan for ovarian cancer
- Lymphadenectomy for the management of endometrial cancer
- Hormonal therapy in advanced or recurrent endometrial cancer
- Maintenance chemotherapy for ovarian cancer
- Adjuvant progestagens for endometrial cancer
- Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer
- Primary groin irradiation versus primary groin surgery for early vulvar cancer
- Interventions for sexual dysfunction following treatments for cancer in women
- Metformin for endometrial hyperplasia
- Non‐surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis
- Chemotherapy for advanced ovarian cancer
- Palliative surgery versus medical management for bowel obstruction in ovarian cancer
- Antigen‐specific active immunotherapy for ovarian cancer
- Adjuvant (post‐surgery) chemotherapy for early stage epithelial ovarian cancer
- Interventions for encouraging sexual behaviours intended to prevent cervical cancer
- Radiotherapy and chemoradiation after surgery for early cervical cancer
- Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease
- Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women
- Surgical interventions for early squamous cell carcinoma of the vulva
- Palliative interventions for controlling vaginal bleeding in advanced cervical cancer
- Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: Cochrane systematic review
- Surgical cytoreduction for recurrent epithelial ovarian cancer
- Combined use of hyperthermia and (chemo)radiation therapy for treating locally advanced cervix carcinoma
- High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer
- Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy
- Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer